|
|
|
|
| LEADER |
02477nam a2200265 u 4500 |
| 001 |
EB002001450 |
| 003 |
EBX01000000000000001164351 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Lau, Joseph
|
| 245 |
0 |
0 |
|a Vulnerable plaques
|h Elektronische Ressource
|b a brief review of the concept and proposed approaches to diagnosis and treatment
|c prepared for, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by the Tufts-New England Medical Center AHRQ Evidence-based Practice Center ; Joseph Lau, David Kent, Athina Tatsioni, Yannan Sun, Chenchen Wang, Priscilla Chew, Bruce Kupelnick, Harmon Jordan
|
| 260 |
|
|
|a Rockville, Maryland
|b Agency for Healthcare Research and Quality
|c 2004, January 22, 2004
|
| 300 |
|
|
|a 1 PDF file (35 pages)
|b illustrations
|
| 710 |
2 |
|
|a United States
|b Agency for Health Care Policy and Research
|
| 710 |
2 |
|
|a Tufts-New England Medical Center
|b Evidence-based Practice Center
|
| 710 |
2 |
|
|a Technology Assessment Program (Agency for Healthcare Research and Quality)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Technology assessment
|
| 500 |
|
|
|a Title from PDF title page
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK285060
|3 Volltext
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The Centers for Medicare & Medicaid Services (CMS) requested from the Agency for Healthcare Research and Quality a brief review of the diagnosis and treatment of vulnerable plaque (VP) of coronary and carotid arteries. The Tufts-New England Medical Center Evidence-based Practice Center was asked to conduct this review. The aims of this report were to: Review the concept(s) of VP. Review any literature and/or statements from experts about the natural history of VP. Review the various methods that have been suggested or actually used to diagnose this condition. Review any information that may be available regarding the conceptual framework, which would inform the evaluation of such diagnostic techniques (e.g., what reference standard would be used in determining the accuracy of a proposed test?). Review any literature and/or statements from experts about how VP, once identified, would be treated. Review how the existence of methods for identifying VP may change the types of treatments or the types of patients who get treatment for carotid or coronary artery occlusions
|